Where to Inject TB-500: Sites and Rotation

TB-500 Ships as Part of a Combo

Before the site map, one fact clears up most of the confusion around this question. PeRx does not dispense TB-500 as a standalone product. It comes pre-mixed with BPC-157 in a single ready-to-use vial called the BPC-157/TB-500 combo. So when you ask where to inject TB-500, you are really asking where to inject the combo, and the answer is one injection that delivers both peptides at once.

This is deliberate. BPC-157 and TB-500 are the two most commonly paired peptides in tissue repair, and they cover different phases of the same healing process. Pre-mixing them at a fixed ratio means you skip the stacking math and the second vial. If you want the full science on why the two are combined, the BPC-157 and TB-500 dosing and timeline guide and why we pair BPC-157 with TB-500 cover it in depth. This page is narrower: it is about where the needle goes.

It Is a Subcutaneous Injection

The BPC-157/TB-500 combo is a subcutaneous (subQ) injection, the same general technique as any other PeRx peptide. The needle enters the fat layer beneath the skin at a 45 to 90 degree angle, not muscle. If peptides are new to you altogether, what peptide therapy is covers the fundamentals first. If you have never done a subQ injection, the full how-to-inject-peptides guide walks through the technique step by step. This guide focuses on what is specific to this combo: which sites to use, when injecting near the injury makes sense, and how to rotate.

The Four Standard Sites

There are four anatomical regions that all subQ peptide injections, including the BPC-157/TB-500 combo, can use. Each has slightly different absorption characteristics and ergonomics.

1. Abdomen. The area between the lower rib cage and the hip bones, avoiding a roughly two-inch radius around the navel. This is the default site for most patients. Fat coverage is generally consistent, the area is easy to see, and absorption is reliable. Use the soft tissue on either side of the belly button rather than directly above or below it.

2. Front or outer thigh. The middle portion of the thigh, on the front (anterior) or outer (lateral) side. The fat layer is usually adequate here and the angle is comfortable for self-injection while seated. Avoid the inner thigh (more vascular) and the immediate area around the knee or hip.

3. Upper outer glute. The upper outer quadrant of the buttock, the same area used for many vaccinations. Harder to reach for self-injection without a mirror or a partner, but the absorption is excellent and the fat coverage tends to be deepest here. Some patients rotate this site in once or twice a week to give the abdomen a rest.

4. Back of the deltoid. The fat pad on the back of the upper arm, just behind the deltoid muscle. Fat coverage varies significantly between patients. If you can pinch a half-inch or more of skin and fat here, it works. If the skin pulls tight against muscle, choose a different region.

Injecting Near the Injury

Here is where the BPC-157/TB-500 combo differs from a purely systemic peptide. This is a tissue-repair protocol, and BPC-157 in particular has its strongest effect near the injection site. That is why many providers have patients inject in the subcutaneous fat near a localized injury, a tendon, a joint, or a muscle, when it is practical, rather than always using the abdomen.

The important detail is that near-injury injection is still subcutaneous. You are injecting into the fat layer over or beside the injured area, not into the tendon, joint capsule, or muscle itself. For a shoulder, that might be the soft tissue over the deltoid area; for a knee, the fat just above or beside the joint; for a hamstring or calf, the subQ tissue over the muscle. If the area is too lean to pinch a fold of skin and fat, do not force it. Use the nearest region that has adequate coverage, or default to the abdomen.

TB-500 works systemically regardless of where you inject, so nothing is lost by using the abdomen on days when the injured area is too tender or too small to rotate within. A common pattern is alternating: near the injury on some days for the localized BPC-157 effect, abdomen on others for consistent systemic delivery. Your prescription is the authority here. Providers prescribe the site strategy that fits your specific injury; they set the protocol, they do not coach you through each dose.

Rotation Schedule

Repeated injection in the same spot causes minor fat-tissue trauma that accumulates over weeks. The result is small palpable nodules, occasional bruising, or thickened tissue that absorbs the next injection less predictably. Rotation prevents this and keeps absorption consistent.

The rule most providers teach is to move at least one inch (a finger-width) from your last injection point every time. Within a single body region, you can subdivide into a grid: the abdomen has roughly eight usable spots if you split it into quadrants on each side of the navel. Cycle through them in order, then move to the next region.

A simple weekly pattern for a localized injury: alternate near-injury days with abdomen days, and within each region move at least an inch from the last spot. For a general recovery protocol with no single target, alternate sides of the abdomen for part of the week, then switch to a thigh, and give each region time to recover before you return to it. Mark the previous spot with a fingernail indent or a small temporary marker if you cannot remember.

Dosing Context

Because the combo is pre-mixed, you are not measuring BPC-157 and TB-500 separately. It is a single subcutaneous injection on a provider-determined schedule, typically daily during an active recovery cycle. The vial arrives at a fixed, calibrated concentration, so your job at each injection is drawing the volume your prescription specifies, nothing more.

Dose, volume, and cycle length depend entirely on what you are healing and what your provider prescribes. For the full picture on cycling, timelines by injury type, and the science behind the pairing, see the BPC-157 and TB-500 dosing and timeline guide. Do not copy generic protocols you find online; the number that matters is the one on your label.

Bock-Marquette I et al., "Thymosin beta-4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair," Nature, 2004. View study

Sikiric P et al., "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract," Current Pharmaceutical Design, 2011. View study

Technique and Common Pitfalls

The general subQ technique (warming the vial, pinching a fold of skin, injecting slowly, applying gentle post-injection pressure) is the same for the BPC-157/TB-500 combo as for any other PeRx peptide and is covered in the how-to-inject-peptides guide. A few pitfalls are worth flagging specifically.

Assuming it goes intramuscular. The single most common mistake with TB-500 is thinking it needs to go into muscle. In the combo PeRx dispenses, the route is subcutaneous. Pinch the fat and stay shallow.

Injecting into the injury instead of near it. Near-injury dosing means the subcutaneous fat over or beside the area, never into the tendon, joint, or broken skin. If you cannot pinch a fold there, move to a region that has coverage.

Injecting through clothing. Even thin fabric is a contamination risk. Lift the shirt and inject into clean skin.

Using the same exact spot every time. Within a few weeks you will have a palpable lump and absorption will become inconsistent. Rotate at least an inch each time.

Injecting into a tattoo, scar, mole, or visible vein. Avoid these entirely. Pick clean skin a few inches away.

Reusing the needle. Insulin syringes are single use. Reusing dulls the needle, which makes injection more painful and increases tissue trauma. PeRx ships ample syringes with each order.

If side effects are what you are weighing before starting, the peptide side effects guide covers what is common, what is rare, and what deserves a call to your provider.

Frequently Asked Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed July 2026